Mallinckrodt, Inc.

Liebel-flarsheim Company LLC

Vernon D Ortenzi

Robert J Ziemba

Chad M Gibson

Frank M Fago

Gary S Wagner

David W Wilson

William E Bausmith

Elaine Borgemenke

Elaine E Haynes

John H Lewis

Brandon Wesley Craft

John Edward Powers

Pamela L Pollard

Rhonda J Soest

Geoffrey S Strobl

James E Knipfer

Frank Lewis

Robert G Moll

Victor Potter

Robin Michael Lee

Simon Alexander Karger

Pari Datta

Andrew Robert Mawby

Jeremy Bickerstaffe

Paul Fearis

Valerie Ann Scott

Debra C Hasse

Pamela J Pollard

Contrast administration data that relates to operation of a contrast media injector system () may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) by an injection data management module () for use by a medical system (). Data on contrast media prescribed for an imaging operation using an imaging system (), contrast media data for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system () for this imaging operation may be stored in a data structure () on the injection data management module (). Patient renal function data may be used to control the dispensing of contrast media from a contrast media/storage/dispensing unit (), to control the operation of the contrast media injector system (), or both, and may be stored in the data structure () as well.

Contrast media injection data management

Contrast administration data that relates to operation of a contrast media injector system () may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) for use by a medical system (). Data on contrast media prescribed for an imaging operation using an imaging system (), data on contrast media dispensed from a contrast media storage/dispensing unit () for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system () for this imaging operation may be stored in a data structure (). Patient renal function data may be used to control the dispensing of contrast media from the contrast media/storage/dispensing unit (), to control the operation of the contrast media injector system (), or both, and may be stored in the data structure () as well.

Contrast media injection data management system

A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).

Sealable secondary packaging for pharmaceutical product blister pack

Various embodiments of pharmaceutical product containers are disclosed. Each pharmaceutical product container includes a cap, a container body, and a locking mechanism. The locking mechanism is disposable from a locked state to an unlocked state at least when the cap is in a closed position relative to the container body (e.g., to define an enclosed space for pharmaceutical product). Once in the locked state and with the cap being in a closed position, the locking mechanism is unable to return to its unlocked state. Pharmaceutical product enclosed within the container with the locking mechanism being in its locked state may then be disposed of in any appropriate manner (e.g., discarded in the trash).

Pharmaceutical product container with permanent locking mechanism

Systems and methods for managing use of a pharmaceutical product are provided. The systems and methods utilize an external cover and a container, along with a first material and a pharmaceutical product that are each contained within an internal space that exists when the external cover is in a closed position relative to the container. Release of the first material may bond the external cover to the container, may result in the first material coming into contact with the pharmaceutical product, or both.

Systems and methods for managing use of a medicament

Pharmaceutical product dispensers (e.g., in the shape of a common ink pen) are operable to indicate information regarding a dosing schedule of a pharmaceutical product dispensable from the dispenser. Embodiments of the dispensers may include a plurality of dosing segments, each corresponding to a different dose of the pharmaceutical product. Actuation of an actuator may result in interaction between the actuator and the pharmaceutical product storage area such that a dose of pharmaceutical product contained in the pharmaceutical product storage area is dispensed, along with a corresponding advancement of the plurality of dosing segments. The dispenser may also include one or more locks to prevent unauthorized access to the pharmaceutical product (e.g., by a child or the like). Furthermore, the pharmaceutical product dispenser may include a disabling mechanism to permanently disable actuation of the actuator of the dispenser.

Pen-type pharmaceutical product dispenser

A pharmaceutical product supply in the form of a container (e.g., secondary packaging) and a pharmaceutical product receiver (e.g., primary packaging) is disclosed. The pharmaceutical product receiver may include a plurality of pockets or receptacles, and may be disposed within the container. Pharmaceutical product may be enclosed within one or more of these receptacles. The pharmaceutical product receiver may be locked to at least some degree within the container to facilitate disposal of the pharmaceutical product supply, for instance at a time when some of the pharmaceutical product may have been removed from the pharmaceutical product receiver but prior to utilizing all of the pharmaceutical product originally provided with the pharmaceutical product receiver.

Pharmacutical product blister pack lockable within secondary packaging

A transdermal patch container () that includes a container body (), a first compartment (), and a second compartment () is disclosed. One or more first transdermal patches () may be stored in the first compartment (). One or more second transdermal patches () may be stored in the second compartment (). The first transdermal patches () differ from the second transdermal patches () in at least one respect. A number of features may be incorporated to reduce the potential of being able to withdraw second transdermal patches () out of the second compartment (). For instance, second transdermal patches () may be required to be directed through a slot () to enter a second compartment (). A flap () may be positioned below such a slot () within a second storage compartment (). A plurality of vertically spaced or staggered flaps () may be positioned within a second storage compartment ().

Disposable transdermal patch packaging

A container () for storing transdermal patches is disclosed. The container () includes a child-resistant mechanism () to reduce the likelihood of access to the transdermal patches (TP) by children. The child-resistant mechanism () may include first and second access components () that may be disposed in a non-opposing manner and that may be in any appropriate form (e.g., buttons). Activation or engagement of the first and second access components () in a particular manner allows the container () to assume an open configuration to access and/or load patches. In one arrangement, the first and second access components () may be simultaneously engaged (e.g., depressed) to open the container (). In another arrangement, the first and second access components () may be engaged in series in a particular sequence to open the container ().

Apparatuses and methods for storing pharmaceutical product

Systems and methods for tracking dosage periods are disclosed. The systems and methods may include setting a timer () to a predetermined value corresponding to a dosage period in response to the engagement of a cover () to a container (). An indication may be provided that corresponds to a remaining period in the dosage period set by the engagement of the cover () and container (). The indication may also indicate a remaining time period in the dosage period.

Systems and methods for timing dosage periods

An apparatus and method of operation is provided for a contrast media injector having a powered drive ram. The drive ram is designed to interface with a plunger of a syringe in order to move the plunger forward and backward relative to a barrel of the syringe. The syringe, having an RF data tag associated therewith, is mounted on to the contrast media injector. Electromagnetic signals are transmitted from an electromagnetic device of the injector in response to mounting the syringe. Data is electromagnetically read from the RF data tag of the syringe using the electromagnetic device of the injector. The transmitting is terminated after the electromagnetically reading. Medical fluid is then dispensed from the syringe. Electromagnetic signals are transmitted from the electromagnetic device in response to initiation of the dispensing. Data is electromagnetically written to the RF data tag of the syringe using the electromagnetic device of the injector.

Systems and methods for managing information relating to medical fluids and syringes therefor

The present invention includes medical fluid injector systems that detect the contents and/or volume of such contents within a syringe of the system. For example, an RF signal from a first antenna of a medical fluid injector may be transmitted through a syringe associated with the medical fluid injector. At least some of the transmitted RF signal may be received by a second antenna of the medical fluid injector. An amount of the RF signal received by the second antenna may be measured to provide information regarding the contents and/or volume of such contents within the syringe.

Growing community of inventors

Burlington, KY, United States of America

Vernon D Ortenzi